These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 33408692)

  • 41. Obesity as a risk factor for COVID-19 mortality in women and men in the UK biobank: Comparisons with influenza/pneumonia and coronary heart disease.
    Peters SAE; MacMahon S; Woodward M
    Diabetes Obes Metab; 2021 Jan; 23(1):258-262. PubMed ID: 32969132
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association between influenza vaccination and SARS-CoV-2 infection and its outcomes: systematic review and meta-analysis.
    Jiang B; Huang Q; Jia M; Xue X; Wang Q; Yang W; Feng L
    Chin Med J (Engl); 2022 Oct; 135(19):2282-2293. PubMed ID: 36378238
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hypertension is a clinically important risk factor for critical illness and mortality in COVID-19: A meta-analysis.
    Du Y; Zhou N; Zha W; Lv Y
    Nutr Metab Cardiovasc Dis; 2021 Mar; 31(3):745-755. PubMed ID: 33549450
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of α1-Blocker Receipt With 30-Day Mortality and Risk of Intensive Care Unit Admission Among Adults Hospitalized With Influenza or Pneumonia in Denmark.
    Thomsen RW; Christiansen CF; Heide-Jørgensen U; Vogelstein JT; Vogelstein B; Bettegowda C; Tamang S; Athey S; Sørensen HT
    JAMA Netw Open; 2021 Feb; 4(2):e2037053. PubMed ID: 33566109
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Visceral adiposity, subcutaneous adiposity, and severe coronavirus disease-2019 (COVID-19): Systematic review and meta-analysis.
    Pranata R; Lim MA; Huang I; Yonas E; Henrina J; Vania R; Lukito AA; Nasution SA; Alwi I; Siswanto BB
    Clin Nutr ESPEN; 2021 Jun; 43():163-168. PubMed ID: 34024509
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Obesity or increased body mass index and the risk of severe outcomes in patients with COVID-19: A protocol for systematic review and meta-analysis.
    Yang Y; Wang L; Liu J; Fu S; Zhou L; Wang Y
    Medicine (Baltimore); 2022 Jan; 101(1):e28499. PubMed ID: 35029905
    [TBL] [Abstract][Full Text] [Related]  

  • 47. National case fatality rates of the COVID-19 pandemic.
    Ergönül Ö; Akyol M; Tanrıöver C; Tiemeier H; Petersen E; Petrosillo N; Gönen M
    Clin Microbiol Infect; 2021 Jan; 27(1):118-124. PubMed ID: 32979575
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Physical interventions to interrupt or reduce the spread of respiratory viruses.
    Jefferson T; Del Mar CB; Dooley L; Ferroni E; Al-Ansary LA; Bawazeer GA; van Driel ML; Jones MA; Thorning S; Beller EM; Clark J; Hoffmann TC; Glasziou PP; Conly JM
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD006207. PubMed ID: 33215698
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Underlying Medical Conditions Associated With Severe COVID-19 Illness Among Children.
    Kompaniyets L; Agathis NT; Nelson JM; Preston LE; Ko JY; Belay B; Pennington AF; Danielson ML; DeSisto CL; Chevinsky JR; Schieber LZ; Yusuf H; Baggs J; Mac Kenzie WR; Wong KK; Boehmer TK; Gundlapalli AV; Goodman AB
    JAMA Netw Open; 2021 Jun; 4(6):e2111182. PubMed ID: 34097050
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association Between Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in Patients With COVID-19: A Systematic Review and Meta-analysis.
    Baral R; Tsampasian V; Debski M; Moran B; Garg P; Clark A; Vassiliou VS
    JAMA Netw Open; 2021 Mar; 4(3):e213594. PubMed ID: 33787911
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increasing adiposity and the presence of cardiometabolic morbidity is associated with increased Covid-19-related mortality: results from the UK Biobank.
    Patel KHK; Li X; Quint JK; Ware JS; Peters NS; Ng FS
    BMC Endocr Disord; 2021 Jul; 21(1):144. PubMed ID: 34217276
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metabolically unhealthy individuals, either with obesity or not, have a higher risk of critical coronavirus disease 2019 outcomes than metabolically healthy individuals without obesity.
    Kim NH; Kim KJ; Choi J; Kim SG
    Metabolism; 2022 Mar; 128():154894. PubMed ID: 34600905
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Obesity as a risk factor for unfavourable outcomes in critically ill patients affected by Covid 19.
    Rossi AP; Gottin L; Donadello K; Schweiger V; Nocini R; Taiana M; Zamboni M; Polati E
    Nutr Metab Cardiovasc Dis; 2021 Mar; 31(3):762-768. PubMed ID: 33549439
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Obesity as a mortality risk factor in the medical ward: a case control study.
    Soffer S; Zimlichman E; Glicksberg BS; Efros O; Levin MA; Freeman R; Reich DL; Klang E
    BMC Endocr Disord; 2022 Jan; 22(1):13. PubMed ID: 34991575
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Population risk factors for severe disease and mortality in COVID-19: A global systematic review and meta-analysis.
    Booth A; Reed AB; Ponzo S; Yassaee A; Aral M; Plans D; Labrique A; Mohan D
    PLoS One; 2021; 16(3):e0247461. PubMed ID: 33661992
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Association Between Previous Influenza Vaccination and COVID-19 Infection Risk and Severity: A Systematic Review and Meta-analysis.
    Su W; Wang H; Sun C; Li N; Guo X; Song Q; Liang Q; Liang M; Ding X; Sun Y
    Am J Prev Med; 2022 Jul; 63(1):121-130. PubMed ID: 35410774
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association of obesity with illness severity in hospitalized patients with COVID-19: A retrospective cohort study.
    Suresh S; Siddiqui M; Abu Ghanimeh M; Jou J; Simmer S; Mendiratta V; Russell S; Al-Shammari M; Chatfield A; Alsheik E; Dang D; Genaw J; Zuchelli T
    Obes Res Clin Pract; 2021; 15(2):172-176. PubMed ID: 33653666
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Underlying Medical Conditions and Severe Illness Among 540,667 Adults Hospitalized With COVID-19, March 2020-March 2021.
    Kompaniyets L; Pennington AF; Goodman AB; Rosenblum HG; Belay B; Ko JY; Chevinsky JR; Schieber LZ; Summers AD; Lavery AM; Preston LE; Danielson ML; Cui Z; Namulanda G; Yusuf H; Mac Kenzie WR; Wong KK; Baggs J; Boehmer TK; Gundlapalli AV
    Prev Chronic Dis; 2021 Jul; 18():E66. PubMed ID: 34197283
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Systemic administration of glucocorticoids, cardiovascular complications and mortality in patients hospitalised with COVID-19, SARS, MERS or influenza: A systematic review and meta-analysis of randomised trials.
    Caiazzo E; Rezig AOM; Bruzzese D; Ialenti A; Cicala C; Cleland JGF; Guzik TJ; Maffia P; Pellicori P
    Pharmacol Res; 2022 Feb; 176():106053. PubMed ID: 34979235
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevalence of co-morbidities and their association with mortality in patients with COVID-19: A systematic review and meta-analysis.
    Singh AK; Gillies CL; Singh R; Singh A; Chudasama Y; Coles B; Seidu S; Zaccardi F; Davies MJ; Khunti K
    Diabetes Obes Metab; 2020 Oct; 22(10):1915-1924. PubMed ID: 32573903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.